Cargando…

Identify Tcea3 as a novel anti-cardiomyocyte hypertrophy gene involved in fatty acid oxidation and oxidative stress

BACKGROUND: Chronic pressure overload triggers pathological cardiac hypertrophy that eventually leads to heart failure. Effective biomarkers and therapeutic targets for heart failure remain to be defined. The aim of this study is to identify key genes associated with pathological cardiac hypertrophy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yingying, Cen, Xian-feng, Li, Dan, Qiu, Hong-liang, Chen, Ya-jie, Zhang, Meng, Huang, Si-hui, Xia, Hao, Xu, Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315901/ https://www.ncbi.nlm.nih.gov/pubmed/37404738 http://dx.doi.org/10.3389/fcvm.2023.1137429

Ejemplares similares

NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
por: Guo, Ningning, et al.
Publicado: (2021)

The β(2)-Subunit of Voltage-Gated Calcium Channels Regulates Cardiomyocyte Hypertrophy
por: Pickel, Simone, et al.
Publicado: (2021)

Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
por: Xu, Ran, et al.
Publicado: (2021)

TCEA3 Attenuates Gastric Cancer Growth by Apoptosis Induction
por: Li, Jia, et al.
Publicado: (2015)

The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma
por: Kazim, Noor, et al.
Publicado: (2020)

Slc39a2-Mediated Zinc Homeostasis Modulates Innate Immune Signaling in Phenylephrine-Induced Cardiomyocyte Hypertrophy
por: Fang, Yu, et al.
Publicado: (2021)

Protective activity of Malus doumeri leaf extract on H(2)O(2)-induced oxidative injury in H9C2 rat cardiomyocytes
por: Shen, Yi, et al.
Publicado: (2022)

Isoprenaline modified the lipidomic profile and reduced β-oxidation in HL-1 cardiomyocytes: In vitro model of takotsubo syndrome
por: Fiserova, Ivana, et al.
Publicado: (2022)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activity
por: Magadum, Ajit, et al.
Publicado: (2022)

The transcription elongation factor TCEA3 promotes the activity of the myogenic regulatory factors
por: Kazim, Noor, et al.
Publicado: (2019)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
por: Yang, Dan, et al.
Publicado: (2022)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

The protective effects of Clerodendranthus spicatus (Thunb.) C. Y. Wu extract on oxidative stress induced by 2,2'-azo (2-methylpropamidine) dihydrochloride in HL-1 mouse cardiomyocytes
por: Li, Ying, et al.
Publicado: (2022)

Deep learning assessment of left ventricular hypertrophy based on electrocardiogram
por: Zhao, Xiaoli, et al.
Publicado: (2022)

17β-Estradiol Inhibits Proliferation and Oxidative Stress in Vascular Smooth Muscle Cells by Upregulating BHLHE40 Expression
por: Feng, Dan-dan, et al.
Publicado: (2021)

Genetic Alterations in Oxidant and Anti-Oxidant Enzymes in the Vascular System
por: Awad, Maan A., et al.
Publicado: (2018)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

Left ventricular hypertrophy with cardiomyocyte atrophy and extensive interstitial fibrosis: a mitochondrial cardiomyopathy
por: Zhang, Xinyu, et al.
Publicado: (2022)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity
por: Zhou, Yawen, et al.
Publicado: (2021)

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)

Ultrastructural Adaptation of the Cardiomyocyte to Chronic Mitral Regurgitation
por: Corporan, Daniella, et al.
Publicado: (2021)

Cardiomyocytes Cellular Phenotypes After Myocardial Infarction
por: Lodrini, Alessandra Maria, et al.
Publicado: (2021)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

FUCCI-Based Live Imaging Platform Reveals Cell Cycle Dynamics and Identifies Pro-proliferative Compounds in Human iPSC-Derived Cardiomyocytes
por: Murganti, Francesca, et al.
Publicado: (2022)

Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality
por: Afify, Hesham M. A., et al.
Publicado: (2018)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1
por: Wang, Shu-hui, et al.
Publicado: (2023)

Cardiomyocyte—Endothelial Cell Interactions in Cardiac Remodeling and Regeneration
por: Talman, Virpi, et al.
Publicado: (2018)

Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac Repair
por: Gomez, Ingrid, et al.
Publicado: (2018)

Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation
por: Onoue, Kenji, et al.
Publicado: (2021)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_01f0pteo8fhakvl3ne1gvtmj8f